Is CBD Legal Throughout Europe?

Can we legally purchase and consume marijuana in France today? Yes and no. Yes, due to the fact that the state has unwinded its guidelines on CBD, consisting of through the Minister of Health. And no, at the same time, due to the fact that just products containing cannabidiol (CBD), an active substance that does not have the psychedelic effects attributed to THC, are considered legal. Let us analyze what is legal and what is not with regard to marijuana and CBD.

CBD is legal in France, however THC is not

Marijuana must not be confused with cannabidiol. Particularly considering that the second is legal in certain types in France … While the other is not! Since cannabidiol (understood by the acronym CBD) is just among the many active substances from the hemp plant, which does not have the psychedelic effects of its cousin THC – the one that makes you “stone”.

In short, what is usually called “marijuana”, which consists of high concentrations of THC (tetrahydrocannabinol) is still considered a narcotic product. And for that reason unlawful in France as in numerous countries on the planet. On the other hand, marijuana which provides pride of place to the cannabinoid referred to as cannabidiol, it is legal as long as its THC levels do not exceed 0.2%.

However, the legislation stays vague in France on this subject. Presently, there is no law that makes it clear whether new earth CBD is legal or not. Concretely, it is licensed for sale in the form of E-liquid, to be used in an electronic cigarette. But it is likewise discovered in other types (consisting of oil or paste), without its purchase and intake being reprehensible … To try to make it basic, let’s state that CBD is not forbidden by French law, unlike THC


Although CBD and THC are identical, they are extremely various. These are the best understood of the 500 cannabinoids discovered in hemp. And each has its specific effects. THC is especially understood for its psychedelic properties: it triggers a modification in the state of awareness by acting straight on the brain. By consuming marijuana abundant in THC, we “hover”: well-being, ecstasy, relaxation … But likewise red eyes, dilated pupils and, often, stress and anxiety or even paranoia.

CBD has nothing to do with it. It is not blissful. It does not cause stress and anxiety or stress and anxiety attacks. On the contrary: cannabidiol remains in the process of making its method by virtue of its useful restorative effects. CBD networks helps alleviate discomfort and swelling, lower stress and anxiety, relieve the suffering of victims of stress and anxiety attacks and depression, and even deal with certain diseases (such as epilepsy or Alzheimer’s). In addition, it has a very low toxicity and presents (nearly) no addictive danger, even if the lack of clinical studies lowers these characteristics to mere hypotheses.

Legalization of CBD in France: should we go further?

Certainly, the legal development concerning CBD is positive, however whatever stays to be done. The health ministry wants to beware, and the federal government’s position on the matter resembles a balancing act. At the same time, the National Medicines Agency has clearly spoken up. We for that reason look after the goat and the cabbage so as not to get too involved, while the vaporized cannabidiol has been offered in France for a couple of years already, benefiting from the legal vagueness that persists.

Beyond the 0.2% THC threshold licensed in marketed products, it must be kept in mind that just the liquid type of CBD (intended for smokeless cigarettes) is truly legal. The purchase and intake of resin or smoking herb is for that reason not managed, specifically considering that the THC level is typically greater (around 15%). In addition, just the use of seeds and fibers is licensed in France. But what about CBD oil, which permits you to enjoy the advantages of the substance without exposing your lungs to possibly hazardous smoke? What about CBD paste? On these subjects, there is radio silence.

In addition, CBD is considered a “dietary supplement”, which restricts providing it as a medicine. And make it an enlightened advertisement for users and patients. Too bad, due to the fact that, in the meantime, numerous potential beneficiaries are not benefiting from it. It is for that reason needed to go further and clarify things: more than a question of customer well-being, it is a matter of public health.

Scroll to top